CAR-T Therapy
Investment in immune cell therapy for cancer treatment, benefiting from CAR-T technology development and commercialization.24H Performance
1.40%
Beta0.56
Pre-market | Last updated at Aug 18, 2026 06:48:19Pre-market | Last updated at Aug 18, 2026 06:48:19